FGF23 levels have even been seen to reach 10,000-fold higher in end-stage renal disease when compared to healthy individuals [47]; however, the comparatively lower fold changes in our study could be due to the fact that the gene expression levels were analyzed in whole blood which is not the primary tissue of production of the FGF23. Here, FGF23 is linked to chronic kidney disease.